Ex Vivo vs. In Vivo Gene Therapy

The distinction between ex vivo and in vivo gene therapy strategies is a core technical concept for Zambian students in genetic engineering, cell therapy, and regenerative medicine. This topic compares and contrasts the two primary approaches: ex vivo therapy, where target cells (e.g., hematopoietic stem cells, T-cells) are removed from the patient, genetically modified in the laboratory, and then reinfused; and in vivo therapy, where the genetic vector is delivered directly into the patient's body. Students will analyze the advantages, challenges, and clinical applications of each method, such as ex vivo therapy for SCID ("bubble boy" disease) and in vivo therapy for retinal disorders. This advanced material is part of biotechnology and molecular medicine curricula at Zambian tertiary institutions, equipping learners for examinations and future roles in cutting-edge biomedical research and clinical trial management. Understanding these strategies is fundamental to developing and applying gene-based treatments.